| Drug Name |
Rifapentine |
| Drug ID |
BADD_D01937 |
| Description |
Rifapentine is an antibiotic drug used in the treatment of tuberculosis. It inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. |
| Indications and Usage |
For the treatment of pulmonary tuberculosis. |
| Marketing Status |
approved; investigational |
| ATC Code |
J04AB05 |
| DrugBank ID |
DB01201
|
| KEGG ID |
D00879
|
| MeSH ID |
C018421
|
| PubChem ID |
135403821
|
| TTD Drug ID |
D0G9IU
|
| NDC Product Code |
40074-0009; 0088-2102; 50090-5063; 68022-7055; 53002-1718 |
| UNII |
XJM390A33U
|
| Synonyms |
rifapentine | 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin | 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin SV | DL 473-IT | Rifapex | Priftin | DL 473 | DL-4-73 | MDL 473 |
